First-Line Highly Effective Therapy Better for Pediatric MS
New research supports the use of highly effective therapies as first-line treatment in children with relapsing-remitting pediatric-onset multiple sclerosis.
Source: medscape.com
Fn Beta News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fn Beta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fn Beta Today - Breaking & Trending Today
Emerging Therapies Foretell New Era for Cutaneous Disorders
Analogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders.
Source: medscape.com
A New Clue Into the Cause, Spread of Parkinson's Disease?
Damaged mitochondrial DNA initiates and spreads Parkinson's disease pathology, potentially opening new avenues for early diagnosis, researchers say.
Source: medscape.com
Data Support Interferon Beta as Therapeutic Target
Response rates in a phase 2 trial of a novel therapy for skin-predominant dermatomyositis were favorable in patients failed by at least one prior standard therapy, prompting plans for a phase 3 trial.
Source: medscape.com
Despite Challenges, Experts Optimistic About MS Therapy's Future
Since the emergence of the first therapy, more than 20 agents with moderate to high efficacy have come to market for relapsing multiple sclerosis – but experts say that's both a blessing and problem.
Source: medscape.com